Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Global program to eliminate elephantiasis has early success in Egypt

24.03.2006


Organizers of a 20-year global effort to eliminate a parasitic infection that is a leading cause of disability have an early victory to savor: a five-year Egyptian elimination campaign has mostly succeeded, according to a new report in the March 25 issue of The Lancet. Infection with the parasites, threadlike filarial worms, can lead to the dramatic, disfiguring swelling known as elephantiasis.



Researchers from Washington University School of Medicine in St. Louis and Ain Shams University in Egypt found that after five years of annual mass treatments with two drugs, rates of filarial infection sharply declined in Egypt.

"The parasite’s transmission efficiency is low, so the thinking is that once we get human infection rates below a critical level, remaining infections will die out without further intervention," says senior author Gary Weil, M.D., professor of medicine and of molecular microbiology at Washington University. "Our assessments suggest that the Egyptian campaign to eliminate these infections, which was implemented by the Egyptian Ministry of Population and Health, has achieved its goals in most areas of the country."


Filarial worms are nematodes closely related to the heartworm parasites that infect dogs and cats. Infections with the worms, which are spread by mosquitoes, can lead to lymphatic filariasis, a condition where the worms lodge in lymphatic vessels. This triggers inflammation that blocks the drainage normally provided by the lymphatic system and leads to massive swelling of the legs, known as elephantiasis, and genital deformities, which are called hydroceles.

"In addition to causing disability, the disfigurement created by elephantiasis is often a source of great social stigmatization," Weil notes.

Epidemiologists estimate 120 million people are infected with filarial worms in 83 tropical countries. Of those infected, approximately 40 million have clinical symptoms. As many as 1.2 billion people are at risk of infection with the parasites, which can live and reproduce for several years inside the human body. According to the World Health Organization (WHO), lymphatic filariasis is a leading cause of chronic disability in the world.

Policymakers at World Health Assembly meetings in 1997 endorsed filariasis as a candidate disease for global elimination for several reasons: the worms that cause the disease are inefficiently transmitted, they are not known to infect any species other than humans and mosquitoes, and they are vulnerable to three drugs, albendazole, ivermectin and DEC (diethylcarbamazine).

"The manufacturers of the first two drugs later generously decided to donate the medicines to the global program," Weil says. "The third medicine is not free but is very inexpensive."

The assembly passed a resolution calling for the elimination of filariasis by 2020. The strategy the WHO chose for eliminating the parasite is called mass drug administration (MDA).

"In regions where the parasite is known to be present, you annually give two medications that kill the worms," Weil explains. "With the exception of pregnant women and children under two years of age, these drugs are given to everyone in the region without testing each person for the infection."

Planners estimated that five annual repetitions of the MDA program would be needed to drive parasite infection rates down to levels where the few remaining infections would die off on their own. Egypt became one of the first countries to start a five-year MDA program in 2000, working to reach 2.5 million people in 181 Egyptian localities affected by lymphatic filariasis.

"The drugs are free or inexpensive, but distribution on this scale in rural villages and poor areas is a big, expensive job," Weil says. "Donations from foundations and wealthy countries helped fund the distribution in Egypt, and more of that same support is needed for campaigns in other countries."

Working in collaboration with colleagues at Washington University including William D. Shannon, Ph.D., associate professor of biostatistics and researchers at Ain Shams in Egypt, Weil developed a plan for assessing the degree to which the Egyptian MDA program was successful. Using several different tests, some of which were developed in Weil’s lab, Egyptian scientists annually assessed infection rates during the MDA program in two villages north of Cairo and two villages south of Cairo. Each village has a population of 3,000 to 5,000.

The tests revealed sharply declining infection rates over the course of the MDA program. For example, tests of first graders for an antibody that reveals prior exposure to the parasite declined from 18.2 percent positive prior to MDA to 0.2 percent positive after the fifth round of MDA. A test for infection in mosquitoes also showed infection rates plummeted after MDA.

Two of the four villages studied did not quite achieve elimination targets after 5 years of MDA; they will receive a sixth round of treatments in 2006 to ensure that the parasite is eliminated.

Assessment of the Egyptian campaign’s results was funded as a part of the International Collaborations in Infectious Diseases Research (ICIDR) program at the National Institutes of Health. Weil recently received a new ICIDR grant for an added $5 million over five years for a larger program to assess and follow-up filariasis elimination in Egypt.

"With new collaborators from Erasmus University in Holland and Smith College in Massachusetts, we will work with the Ain Shams University group to monitor 44 Egyptian villages, checking to see if remaining infections die out as expected or if the parasite shows any signs of resurgence," he says. "We’ll also be looking at the goals WHO has set for these programs in terms of how far we need to drive infection rates down: are the current targets too stringent? Would it be helpful to have phased goals?"

Weil notes that the filariasis elimination program, which is now coordinating MDA treatments in 35 nations, has to confront a diverse array of economic, cultural and logistical obstacles.

He praises the Egyptian health ministry’s efforts to increase acceptance of the need to participate in the MDA program, noting that it used approaches such as educational comic books and television advertisements featuring Egyptian celebrities to promote public awareness.

"The world faces many challenges in bringing this kind of MDA campaign to the 83 nations where the parasite is present, but this first assessment of a completed five-year MDA program is very encouraging," Weil says.

Michael Purdy | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

From rocks in Colorado, evidence of a 'chaotic solar system'

23.02.2017 | Physics and Astronomy

'Quartz' crystals at the Earth's core power its magnetic field

23.02.2017 | Earth Sciences

Antimicrobial substances identified in Komodo dragon blood

23.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>